Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centromere protein S (CENP-S) is a DNA-binding protein that forms part of the constitutive centromere-associated network (CCAN) and is a component of a nucleosome-like complex at the centromere, including CENP-T, CENP-W, and CENP-X[1]. This complex is involved in the structural assembly and functional switching of the centromere during the cell cycle, converting centromeric chromatin into a mitosis-competent state after DNA replication. CENP-S participates in kinetochore assembly by acting as a chromatin receptor for mitotic machinery, and also has a role in the cellular response to DNA damage as a component of the Fanconi anemia (FA) repair pathway, where it is essential for activation of the FA pathway and maintenance of genomic stability[1][3]. Loss or dysfunction of CENP-S can lead to impaired chromosome segregation, genomic instability, and is relevant to cancer and Fanconi anemia pathogenesis. There are currently no drugs that specifically target CENP-S, and it is not employed as a clinical biomarker.
No known drugs directly target CENP-S; DNA repair modulation and chromosome segregation are general mechanisms in its pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centromere protein S (CENP-S).